Benzinga · Jul 24, 2026
New AI ETF Bets on Healthcare's $9 Trillion Opportunity
Tema's new Healthcare AI ETF (HLTH), targets AI-powered drug discovery, diagnostics, robotics and patient care.
HL
NASDAQ · HLTH
Cue Health Inc.
Healthcare · Medical - Healthcare Information Services
$29.36
Up+$1.34 (+4.78%)
Updated Sep 18, 2026, 3:07 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 6.9M
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 10.65K
- Avg. volume
- 23.24M
Price performance
HLTH price history
1M range · 0 trading sessions · Daily adjusted prices
HLTH does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest HLTH news
The latest Smart Investors Daily articles mentioning HLTH.
Stock researchCompany · Overview
HLTH research
Overview
Company profile and research snapshot.
Company profile
Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows integrations with third-party applications and sensors. It also provides COVID-19 testing kits for the Cue Health Monitoring System The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $8.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Mar 14, 2024 | BTIG | Neutral | — |
| Nov 10, 2023 | Goldman Sachs | Neutral | — |
| Jun 5, 2023 | Goldman Sachs | Neutral | — |
| Jun 2, 2023 | Goldman Sachs | Neutral | — |
| May 15, 2023 | BTIG | Buy | — |
News briefing
No generated briefing is available yet.
Zacks Investment Research · May 9, 2024
AMN Healthcare Services (AMN) Q1 Earnings and Revenues Surpass Estimates
AMN Healthcare (AMN) delivered earnings and revenue surprises of 4.30% and 0.73%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Zacks Investment Research · Oct 12, 2023
Augmedix, Inc. (AUGX) Soars 7.6%: Is Further Upside Left in the Stock?
Augmedix, Inc. (AUGX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks Investment Research · Aug 9, 2023
Cue Health Inc. (HLTH) Reports Q2 Loss, Tops Revenue Estimates
Cue Health Inc. (HLTH) delivered earnings and revenue surprises of 3.77% and 10.23%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
